Yüklüyor......
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models
BACKGROUND: Antibody-drug conjugates (ADCs) are an emerging technology consisting of an antibody, linker, and toxic agent, which have the potential to offer a targeted therapeutic approach. A novel target recently explored for the treatment of pancreatic cancer is guanylyl cyclase C (GCC). The objec...
Kaydedildi:
| Yayımlandı: | Clin Cancer Drugs |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324574/ https://ncbi.nlm.nih.gov/pubmed/30631747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/2212697X05666180516120907 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|